Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol.

Key Points

• The study aims to evaluate the effectiveness of therapeutic fasting in reducing musculoskeletal symptoms associated with aromatase inhibitor therapy in breast cancer patients.
• Conduct a feasibility study with breast cancer patients undergoing aromatase inhibitor therapy.
• Implement therapeutic fasting protocols and monitor patient symptoms.
• Assess changes in musculoskeletal symptoms through standardized measures.
• Potential reduction in musculoskeletal symptoms was observed.
• Feasibility of implementing fasting protocols was determined.
• Patient adherence and response to fasting were recorded.